ProMIS Neurosciences, Inc. (PMN) a un PER historique négatif de -0.5, ce qui signifie que l'entreprise est actuellement non rentable sur la base des douze derniers mois (TTM). Le rendement bénéficiaire historique est de -189.17%.
Critères prouvés par cette page:
Score Global SharesGrow : 57/100 avec 3/7 critères réussis.
| Year | P/E (TTM) | Ratio PEG | Ratio P/B | Ratio P/S | Rendement du Dividende |
|---|---|---|---|---|---|
| 2016 | -8.9 | -1.26 | 328.74 | 11,400.72 | - |
| 2017 | -8.7 | -0.16 | 27.01 | 5,264.03 | - |
| 2018 | -8.7 | -0.26 | 56.46 | 187,190.07 | - |
| 2019 | -5.9 | 0.20 | 110.07 | 36,457.59 | - |
| 2020 | -5.1 | 0.18 | -28.69 | 18,622.94 | - |
| 2021 | -5.0 | -0.06 | 6.74 | 5,930.63 | - |
| 2022 | -1.8 | -1.00 | -17.84 | 0.00 | - |
| 2023 | -0.8 | 0.05 | 3.77 | 0.00 | - |
| 2024 | 8.8 | -0.08 | 1.49 | 0.00 | - |
| 2025 | -0.3 | 0.00 | -9,533.86 | 0.00 | - |
| Year | EPS (Dilué) | Chiffre d'Affaires | Résultat Net | Marge Nette |
|---|---|---|---|---|
| 2016 | $-0.91 | $2K | $-2.57M | -128395.4% |
| 2017 | $-1.40 | $7.87K | $-4.79M | -60836.9% |
| 2018 | $-1.87 | $349.00 | $-7.46M | -2138862.5% |
| 2019 | $-1.31 | $920.00 | $-5.66M | -615447.9% |
| 2020 | $-0.93 | $1.4K | $-4.44M | -316954.7% |
| 2021 | $-1.67 | $8.14K | $-9.66M | -118657.8% |
| 2022 | $-1.70 | $0.00 | $-12.74M | - |
| 2023 | $-1.42 | $0.00 | $-17.51M | - |
| 2024 | $0.11 | $0.00 | $2.78B | - |
| 2025 | $-22.61 | $0.00 | $-39.72B | - |
| Year | EPS (Moy.) | Fourchette EPS | CA (Moy.) | Fourchette CA | Analystes |
|---|---|---|---|---|---|
| 2026 | $-4.38 | $-4.38 – $-4.38 | $0.00 | $0.00 – $0.00 | 1 |
| 2027 | $-4.02 | $-4.62 – $-3.33 | $0.00 | $0.00 – $0.00 | 3 |
| 2028 | $-2.98 | $-3.84 – $-1.87 | $18M | $18M – $18M | 3 |
| 2029 | $-3.22 | $-3.22 – $-3.22 | $73.5M | $73.5M – $73.5M | 1 |
| 2030 | $-0.91 | $-0.91 – $-0.91 | $44.85M | $44.85M – $44.85M | 1 |
